| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
10,098 |
7,487 |
$548K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,526 |
2,828 |
$176K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,163 |
4,632 |
$93K |
| 81226 |
|
184 |
182 |
$64K |
| 81225 |
|
183 |
181 |
$41K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
280 |
267 |
$27K |
| 81328 |
|
183 |
181 |
$25K |
| 81231 |
|
183 |
181 |
$25K |
| 81230 |
|
183 |
181 |
$25K |
| 81227 |
|
183 |
181 |
$25K |
| 87581 |
|
2,734 |
2,181 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,587 |
2,034 |
$17K |
| 87541 |
|
2,572 |
2,020 |
$16K |
| 87486 |
|
2,735 |
2,182 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,053 |
1,569 |
$15K |
| 81355 |
|
183 |
181 |
$12K |
| 87900 |
|
396 |
369 |
$11K |
| 81241 |
|
183 |
181 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
843 |
731 |
$10K |
| 81350 |
|
65 |
64 |
$9K |
| 81240 |
|
183 |
181 |
$9K |
| 81291 |
|
183 |
181 |
$9K |
| 87653 |
|
602 |
564 |
$5K |
| 87481 |
|
602 |
564 |
$5K |
| 87503 |
|
1,823 |
1,339 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
412 |
369 |
$4K |
| 87500 |
|
396 |
369 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
87 |
81 |
$2K |
| 81401 |
|
183 |
181 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14 |
14 |
$513.28 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
110 |
106 |
$344.76 |
| 80061 |
Lipid panel |
187 |
181 |
$260.41 |
| 80053 |
Comprehensive metabolic panel |
221 |
214 |
$181.62 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
199 |
192 |
$122.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
170 |
165 |
$117.60 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
182 |
176 |
$77.41 |
| 84153 |
|
61 |
59 |
$62.53 |
| 36415 |
Collection of venous blood by venipuncture |
319 |
305 |
$18.19 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
47 |
40 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
138 |
132 |
$0.00 |